{"log_id": 2634617391646080862, "direction": 0, "words_result_num": 40, "words_result": [{"probability": {"variance": 0.007392, "average": 0.960157, "min": 0.579345}, "location": {"width": 727, "top": 197, "height": 27, "left": 246}, "words": "潜在的致死性的机会性感染,特别是卡氏肺囊虫性肺炎,可以发生在甲氨蝶呤治疗过"}, {"probability": {"variance": 0.016119, "average": 0.8678, "min": 0.740841}, "location": {"width": 43, "top": 229, "height": 23, "left": 247}, "words": "程中"}, {"probability": {"variance": 0.006835, "average": 0.969099, "min": 0.553873}, "location": {"width": 632, "top": 270, "height": 25, "left": 248}, "words": "使用甲氨蝶呤的同时进行放射治疗可能会增加软组织坏死和骨坏死的风险"}, {"probability": {"variance": 0.017984, "average": 0.910361, "min": 0.603535}, "location": {"width": 241, "top": 312, "height": 25, "left": 248}, "words": "肾功能损害隧常见的热症"}, {"probability": {"variance": 0.01406, "average": 0.944992, "min": 0.426168}, "location": {"width": 778, "top": 353, "height": 26, "left": 195}, "words": "7.腹泻和溃疡性口腔炎是常见的性反商,需要中斯治疗。此外也可能发生出血性肠炎"}, {"probability": {"variance": 0.000149, "average": 0.989784, "min": 0.968048}, "location": {"width": 160, "top": 386, "height": 23, "left": 249}, "words": "和致死性的肠穿孔"}, {"probability": {"variance": 0.027056, "average": 0.915561, "min": 0.39877}, "location": {"width": 726, "top": 426, "height": 26, "left": 247}, "words": "曾有道输注甲氨典呤(常为大剂)的同时使用维体类抗炎药( NSAIDS)后出"}, {"probability": {"variance": 0.00858, "average": 0.945037, "min": 0.695195}, "location": {"width": 689, "top": 456, "height": 26, "left": 248}, "words": "现不可预知的严重的(有时是致死的)骨抑制、再生碍性贫血和胃肠道毒性"}, {"probability": {"variance": 0.003199, "average": 0.974818, "min": 0.723202}, "location": {"width": 778, "top": 498, "height": 25, "left": 196}, "words": "9.甲氨蝶呤诱发的肺部疾病,包括急性或慢性的质性肺炎是一种潜在的危险损害,有报"}, {"probability": {"variance": 0.003672, "average": 0.97708, "min": 0.6869}, "location": {"width": 727, "top": 528, "height": 25, "left": 248}, "words": "道在低剂量用药时它们可能急性发作产治疗的任何时期。这种损伤并不都是完全可逆"}, {"probability": {"variance": 0.002625, "average": 0.974069, "min": 0.744894}, "location": {"width": 724, "top": 558, "height": 26, "left": 250}, "words": "的,并且有因此死亡的报道。如出现肺部症状(尤是无痰性干咳、呼吸困难)可能"}, {"probability": {"variance": 0.025294, "average": 0.908698, "min": 0.372024}, "location": {"width": 725, "top": 589, "height": 27, "left": 249}, "words": "需要中断治疗并且给予信细的检查。肺部损伤在任何剂下甚至低至每周7.5mg剂量"}, {"probability": {"variance": 0.016615, "average": 0.957643, "min": 0.356522}, "location": {"width": 616, "top": 619, "height": 26, "left": 248}, "words": "都会发生,需要排除感染包括肺炎)。需要密切监测患者的肺部症状"}, {"probability": {"variance": 0.009615, "average": 0.94994, "min": 0.590413}, "location": {"width": 775, "top": 660, "height": 26, "left": 200}, "words": "0.大剂量甲氨蝶呤结合亚叶酸(叶酸钙)解救用于特定的肿瘤性疾病的实验性治疗。上"}, {"probability": {"variance": 0.005103, "average": 0.975694, "min": 0.595206}, "location": {"width": 726, "top": 691, "height": 25, "left": 250}, "words": "述操作程序尚在研究中并社是危险的。在没有必要的专业技术和资游组合的设施下不"}, {"probability": {"variance": 0.021553, "average": 0.901547, "min": 0.507292}, "location": {"width": 497, "top": 722, "height": 24, "left": 250}, "words": "能尝试使用人剂量甲氨蝶。有必要查阅最新发表的文就"}, {"probability": {"variance": 1e-06, "average": 0.999376, "min": 0.997271}, "location": {"width": 108, "top": 806, "height": 24, "left": 203}, "words": "【注意事项】"}, {"probability": {"variance": 0.004449, "average": 0.975484, "min": 0.786894}, "location": {"width": 183, "top": 837, "height": 24, "left": 236}, "words": "在下述情况下需慎用"}, {"probability": {"variance": 0.00457, "average": 0.970071, "min": 0.665502}, "location": {"width": 739, "top": 867, "height": 26, "left": 237}, "words": "甲氨蝶呤只能由有抗代谢药物化疗经验的医生使用,如果是非肿瘤的情况则必须由专科"}, {"probability": {"variance": 0.012191, "average": 0.945893, "min": 0.555729}, "location": {"width": 777, "top": 898, "height": 26, "left": 198}, "words": "医生使用。因为有命或严重的毒性反应的可能、医生必须充分告知患者存在的风险,并且"}, {"probability": {"variance": 0.001416, "average": 0.982767, "min": 0.824754}, "location": {"width": 555, "top": 930, "height": 24, "left": 199}, "words": "应该在其监督下用药,应有适当的设施来处理可能发生的并发症"}, {"probability": {"variance": 0.006918, "average": 0.97194, "min": 0.491723}, "location": {"width": 773, "top": 961, "height": 26, "left": 200}, "words": "在大剂量使用或药物排泄减弱(肾功能损害,胸控积液,腹水)的情况下,必须严密监测"}, {"probability": {"variance": 0.00886, "average": 0.964304, "min": 0.613661}, "location": {"width": 710, "top": 992, "height": 25, "left": 199}, "words": "药物毒性反应。曾有过关于使用甲氨蝶呤治疗恶性肿瘤和银屑病后导致死亡的报道"}, {"probability": {"variance": 0.004463, "average": 0.97261, "min": 0.616336}, "location": {"width": 740, "top": 1054, "height": 27, "left": 237}, "words": "在治疗银屑病时甲氨蝶呤仅限用下对其它治疗方式疗效不明显的严重、顽固和致残性病"}, {"probability": {"variance": 0.01342, "average": 0.956889, "min": 0.494201}, "location": {"width": 480, "top": 1085, "height": 25, "left": 240}, "words": "例,并且只能在组织活检和或适当会诊明确诊断后使用"}, {"probability": {"variance": 0.008518, "average": 0.96146, "min": 0.582766}, "location": {"width": 726, "top": 1116, "height": 25, "left": 240}, "words": "甲氨蝶呤可以引起显著的骨髓抑制、贫血、再生障碍性贫血、白细胞减少、中性粒纠"}, {"probability": {"variance": 0.019466, "average": 0.93001, "min": 0.532463}, "location": {"width": 726, "top": 1148, "height": 23, "left": 240}, "words": "胞减少、血小板减少和出,甲氨蝶呤可能具有脏毒性,特别是在大剂量或长时间"}, {"probability": {"variance": 0.008346, "average": 0.965258, "min": 0.488044}, "location": {"width": 732, "top": 1178, "height": 25, "left": 240}, "words": "治疗的情况下曾报道有肝萎缩、肝坏死、肝硬化、脂肪变性和门静脉纤维化。由于"}, {"probability": {"variance": 0.012374, "average": 0.962058, "min": 0.351595}, "location": {"width": 738, "top": 1208, "height": 26, "left": 237}, "words": "这些反应可以没有胃脸道或血液学每性的预兆下发生,新以必须在治疗开始前评估"}, {"probability": {"variance": 0.008285, "average": 0.94595, "min": 0.616109}, "location": {"width": 735, "top": 1240, "height": 25, "left": 239}, "words": "肝功能,并且在治疗的过程中定期监测,在已有肝细地损害或肝功能受损的情况下要"}, {"probability": {"variance": 0.010984, "average": 0.957238, "min": 0.462989}, "location": {"width": 736, "top": 1270, "height": 26, "left": 239}, "words": "特别注意。必须避免同时使用它有潜在肝毒性的药物(包括酒精)。肾功能损害是"}, {"probability": {"variance": 0.04924, "average": 0.88566, "min": 0.392743}, "location": {"width": 124, "top": 1304, "height": 25, "left": 239}, "words": "常见的禁忌"}, {"probability": {"variance": 0.020188, "average": 0.918803, "min": 0.507926}, "location": {"width": 737, "top": 1332, "height": 27, "left": 243}, "words": "当体质虚弱和儿童患使用甲氨蝶岭时要格外道慎。了老年患者的肝功能和肾功能都"}, {"probability": {"variance": 0.013127, "average": 0.959343, "min": 0.471698}, "location": {"width": 731, "top": 1363, "height": 28, "left": 240}, "words": "减弱而且体内叶酸也减少,需要给予相对的低,而上此类思者用药叶需严密监测"}, {"probability": {"variance": 0.014617, "average": 0.937886, "min": 0.464362}, "location": {"width": 734, "top": 1395, "height": 30, "left": 239}, "words": "在银屑病患者中,急性所炎和慢性细胞毒性的发生拟平不仅与药物的累积剂量有关"}, {"probability": {"variance": 0.007788, "average": 0.957371, "min": 0.602633}, "location": {"width": 737, "top": 1426, "height": 27, "left": 241}, "words": "也与下述情况的同时存在有关,如酒精中毒、肥胖康糖尿病、老年以及摄入含砷剂的"}, {"probability": {"variance": 0.020648, "average": 0.926578, "min": 0.353292}, "location": {"width": 735, "top": 1458, "height": 27, "left": 240}, "words": "化合物。慢性毒性是潛在死的,通常在长期使用(一般为2年或更长)和总别积剂"}, {"probability": {"variance": 8.9e-05, "average": 0.994672, "min": 0.966968}, "location": {"width": 171, "top": 1491, "height": 25, "left": 241}, "words": "至少为1.5g时发生"}, {"probability": {"variance": 0.00446, "average": 0.9732, "min": 0.696568}, "location": {"width": 721, "top": 1522, "height": 26, "left": 240}, "words": "存在骨髓发育不良、白细胞减少、血小板减少或贫的恶性肿瘤患者,药物使用需谨慎"}, {"probability": {"variance": 0.015005, "average": 0.952658, "min": 0.477928}, "location": {"width": 635, "top": 1553, "height": 24, "left": 199}, "words": "量放射治疗与甲氨蝶呤治疗同时进行会增加软组织坏死和骨坏死的风险"}], "language": 3}